Trials / Completed
CompletedNCT03820024
MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback
The MOVES Trial: MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Overweight and obese endometrial cancer (EC) survivors at the University of North Carolina (UNC) at Chapel Hill will be approached for tailored feedback fitness intervention. The investigators plan to enroll 36 women (18 in each arm) to evaluate if receipt of weekly tailored feedback messages can improve physical activity in EC survivors. It is hypothesized that women receiving the feedback message intervention will increase step counts from baseline more than 2,000 steps compared to women in the non-intervention arm.
Detailed description
Objectives: * To assess if a tailored feedback fitness intervention can increase physical activity in EC survivors from baseline to 12 weeks post-baseline * To determine the acceptability of the fitness intervention in EC survivors through a completion survey. * To assess if a tailored feedback message fitness intervention can (1) decrease BMI, (2) reduce waitst to hip (W.H) ratios, (3) improve quality of life (QOL) and (4) improve serum metabolic markers (insulin, glucose and low density lipoprotein (LDL) in EC survivors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Tailored Feedback Messages | Participants randomized to the message arm will begin receiving encouragement and reminder UNC CHART messages to increase physical activity weekly. Participants on the feedback arm will receive 1 message per week during the 3-month study period. |
Timeline
- Start date
- 2018-09-28
- Primary completion
- 2019-12-23
- Completion
- 2020-12-23
- First posted
- 2019-01-29
- Last updated
- 2021-07-29
- Results posted
- 2021-07-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03820024. Inclusion in this directory is not an endorsement.